Allene M. Diaz, Director at IONIS PHARMACEUTICALS INC (IONS), sold 657 shares at $41.05 ($27K) on 2023-08-01, disclosed to the SEC on 2023-08-03.
Scheduled sale ($27k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| IONS | SELL | 2025-08-26 | $121K | — | Filing → |
| IONS | SELL | 2024-07-17 | $81K | — | Filing → |